Editorial: Endocrine regulation of aging: impacts of humoral factors and circulating mediators

Benjamin Petersen; Sharon Negri; Madison Milan; Zeke Reyff; Cade Ballard; Jennifer Ihuoma; Zoltan Ungvari; Stefano Tarantini

doi:10.3389/fendo.2024.1387435

Editorial: Endocrine regulation of aging: impacts of humoral factors and circulating mediators

Front Endocrinol (Lausanne). 2024 Mar 6:15:1387435. doi: 10.3389/fendo.2024.1387435. eCollection 2024.

Authors

Benjamin Petersen^{1

2}, Sharon Negri^{1

2}, Madison Milan^{1

2}, Zeke Reyff^{1

2}, Cade Ballard^{1

2}, Jennifer Ihuoma^{1

2}, Zoltan Ungvari^{1

2

3}, Stefano Tarantini^{1

2

3

4

5}

Affiliations

¹ Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
² Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
³ International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
⁴ Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
⁵ Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

No abstract available

Keywords: VCID; age-related disease; healthspan and lifespan; molecular mechanism; therapeutic targets.

Publication types

Editorial

MeSH terms

Aging*
Endocrine System*
Humans

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Institute on Aging (NIA R03AG070479, NIA K01AG073614 and R21AG080775), the American Heart Association (AHA CDA941290), the HEvolution Foundation, the NIA-supported Geroscience Training Program in Oklahoma (T32AG052363), the NIA-supported Oklahoma Nathan Shock Center, and the NIGMS-supported Center of Biomedical Research Excellence (CoBRE) (1P20GM125528-01A1). This research was also supported by the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS.